Clinical Trial Update: VentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Pivotal Trial [Phase 3]

View source ↗

Summary

This update covers a pivotal Phase 3 trial evaluating the VentrAssist LVAD as a bridge to heart transplantation for patients with end-stage heart failure and ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Heart Failure

Drugs mentioned

• VentrAssist LVAD

Snippet

Sponsor: Ventracor | Conditions: End-stage Heart Failure, Cardiomyopathies | Phase 3 | Status: UNKNOWN